Masimo (NASDAQ: MASI) today announced that its management will participate in the Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 11:30 a.m. Eastern Time. A live webcast of the ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Note that the Masimo trade secret lawsuit against Apple is separate from both an ITC injunction preventing the sale of Apple ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, ...

Abstract: The utilization of fluorescence detection for various bio-medical applications such as oximeter sensor, cancer detection, monitor of protein-DNA interactions, heart stroke detection etc. has ...

Vanderbilt University Medical Center is launching Masimo Radius VSM™ advanced wireless patient-worn vital signs monitoring ...

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...

Apple's legal team argued that Masimo had copied the Apple Watch's design and functionality, focusing on the device's aesthetic appeal rather than its innovative pulse oximetry technology.

This is the latest development in the long legal battle between Masimo, a medical tech firm, and Apple in which the former alleges the latter unlawfully incorporated its pulse oximetry tech into the ...

We want them to stop copying our design” and features,” Apple attorney said, lambasting Masimo for focusing on its innovations in pulse oximetry, the blood-oxygen measurement feature.

Apple got a mixed victory in a patent infringement lawsuit against medical device maker Masimo. On Friday, a federal jury determined that Masimo had infringed on some Apple patents, and as part of ...